Dual antiplatelet therapy in the acute phase following stroke and transient ischaemic attack (TIA): which is the best regimen? "AMBDAP "

Completed

Phase N/A Results N/A

Summary of Purpose

To determine optiminal therapy to prevent recurrent stroke

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 27 October 2009.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • The Stroke Association (UK) - research project grant

Trial Design

Interventional, randomised double-blinded single-centre study.

Contacts

Not available